- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07618104
Pornography Abstinence and Nocturnal Erections in Adult Men
A Real-World Observational Study Evaluating the Effects of 30 Days of Pornography Abstinence on Nocturnal Penile Tumescence, Sexual Function, and Well-Being in Adult Men
The effects of pornography use on male sexual health remain uncertain, with mixed findings across existing literature and substantial variability at the individual level. This observational study is designed to help participants evaluate how a 30-day period of pornography abstinence affects their own sexual health and well-being, with a specific focus on nocturnal penile tumescence as a physiological biomarker.
Participants will complete a short baseline observation period during which they maintain their usual pornography consumption patterns, followed by a 30-day abstinence period. Objective nocturnal erection data will be collected using a connected wearable device, alongside validated self-report questionnaires assessing erectile function, sexual desire, mood, energy, and emotional well-being. Participants serve as their own control, allowing for within-person comparisons of outcomes before and during the abstinence period.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This single-arm, real-world observational study evaluates the association between pornography abstinence and changes in nocturnal penile tumescence, sexual function, and psychosocial outcomes in adult men.
During an initial baseline phase, participants continue their typical pornography use while collecting objective nocturnal erection data and completing baseline questionnaires. Participants then enter a 30-day abstinence period, during which they attempt to refrain from pornography use. Abstinence adherence is self-reported, with lapses logged as observational data rather than protocol violations.
Nocturnal penile tumescence is assessed nightly using the Adam Sensor, a non-invasive wearable device that measures changes in penile circumference during sleep. Additional outcomes are assessed using validated questionnaires administered at baseline and at weekly intervals. The study is exploratory and signal-detecting in nature and is not designed to establish causality.
Study Design
Study Type: Observational
Study Design: Single-arm, within-participant comparison
Time Perspective: Prospective
Masking: None (Open Label)
Primary Purpose: Health outcomes assessment / signal detection
Additional information can be found at the study recruitment landing page here: https://app.efforia.com/30-day-tv-abstinence-challenge/
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Matthew Amsden
- Phone Number: (646) 679-2479
- Email: help@efforia.com
Study Locations
-
-
New York
-
New York, New York, United States, 10003
- Recruiting
- Efforia
-
Contact:
- Matthew Amsden
- Phone Number: (646) 679-2479
- Email: help@efforia.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adult males of legal age of consent
- Willingness to attempt pornography abstinence
- Ability to use a wearable device during sleep
- Ability to complete electronic surveys
- Willingness to purchase the study device
Exclusion Criteria:
- Have a history of significant sexual dysfunction requiring active medical treatment
- Have current or uncontrolled mental health disorders
- Have a history of addictive behaviors that may be exacerbated by abstinence
- Are undergoing hormonal therapy or treatment affecting sexual function
- Are experiencing unstable interpersonal or relationship stressors
- Have significant concerns about privacy related to sexual health data
- Have cultural or religious considerations that could cause distress
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Single Arm longitudinal where participants act as their own control
|
Participants will attempt to abstain from all pornography use for 30 consecutive days.
Any deviations from abstinence are self-reported and logged for contextual analysis.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Nocturnal Penile Tumescence
Time Frame: Baseline Day to Day 38
|
Measure: Adam Sensor - Nocturnal Erection Tracking Description: Objective measurement of nocturnal penile tumescence, Frequency/Time nocturnal erections per night |
Baseline Day to Day 38
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Erectile Function
Time Frame: Baseline to Day 38 after intervention
|
Measure: International Index of Erectile Function (IIEF-15) Scale Range: 5-75 (higher scores indicate better erectile and sexual function) Description: Assesses erectile function, orgasmic function, sexual desire, intercourse satisfaction, and overall satisfaction. |
Baseline to Day 38 after intervention
|
|
Change in Sexual Desire
Time Frame: Baseline to Day 38 after intervention
|
Measure: Sexual Desire Inventory-2 (SDI-2) Scale Range: 0-112 (higher scores indicate greater sexual desire) Description: Measures both dyadic and solitary sexual desire. |
Baseline to Day 38 after intervention
|
|
Change in Pornography Consumption Patterns
Time Frame: Baseline to Day 38 after intervention
|
Measure: Weekly Pornography Consumption Survey (custom self-report) Scale: Frequency and duration categories (ordinal) Description: Tracks self-reported pornography use and abstinence adherence. |
Baseline to Day 38 after intervention
|
|
Change in Mood, Energy, and Emotional Well-Being
Time Frame: Baseline to Day 38 after intervention
|
Measure: Weekly Self-Assessment Check-In (custom) Scale: 1-10 Likert-type scales (higher scores indicate more favorable states) Description: Assesses perceived mood, mental clarity, energy level, and emotional resilience. |
Baseline to Day 38 after intervention
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 38321
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Erection; Incomplete
-
Etienne Xavier KellerRecruitingErection; IncompleteSwitzerland
-
Gynuity Health ProjectsDepartment of Medical Research, Lower MyanmarCompletedIncomplete AbortionMyanmar
-
Karolinska InstitutetCompletedIncomplete AbortionUganda
-
Gynuity Health ProjectsCompleted
-
Gynuity Health ProjectsCompletedIncomplete AbortionEgypt, Burkina Faso, Mauritania, Niger, Senegal
-
Gynuity Health ProjectsCompletedIncomplete AbortionNigeria
-
Navamindradhiraj UniversityActive, not recruiting
-
Makerere UniversityLondon School of Hygiene and Tropical Medicine; Karolinska InstitutetCompletedIncomplete AbortionUganda
-
Gynuity Health ProjectsCompletedIncomplete AbortionEcuador, Venezuela
-
Fundació Sant Joan de DéuHospital San Juan de Dios, SpainNot yet recruitingIncomplete Spinal Cord Injury (SCI)Spain
Clinical Trials on Pornography Abstinence
-
UConn HealthThe Center for Advanced Reproductive Services, P.C.RecruitingInfertility | Male Factor InfertilityUnited States
-
RAI Services CompanyCompleted
-
Duke UniversityNational Institutes of Health (NIH)Completed
-
Aalborg UniversityAalborg University HospitalCompleted
-
Wake Forest University Health SciencesNational Institute on Drug Abuse (NIDA)Completed
-
Gazi UniversityCompleted
-
Duke UniversityNational Institutes of Health (NIH)Completed
-
National Taiwan University HospitalNot yet recruitingProstate Cancer Patients Undergoing Radical ProstatectomyTaiwan
-
Massachusetts General HospitalCompletedCognitive Change | Cannabis Use | Adolescent BehaviorUnited States
-
Babes-Bolyai UniversityCompleted